Results 101 to 110 of about 16,213 (203)

Economic Evaluation of Caspofungin versus Liposomal Amphotericin B for Empiric Antifungal Treatment in Patients with Neutropenic Fever in Italy

open access: yes, 2008
ObjectiveTo evaluate the cost-effectiveness of caspofungin versus liposomal amphotericin B as empiric antifungal treatment in patients with neutropenic fever in Italy.MethodsThe cost-effectiveness of caspofungin versus liposomal amphotericin B was ...
Stam, Wiro B.   +6 more
core   +1 more source

Visceral Leishmaniasis (VL) Clinical Presentation, Laboratory Findings, Treatment Options and Outcome

open access: yesIranian Journal of Parasitology
Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment.
Mahmoud Khodabandeh   +3 more
doaj  

Combination Therapy for Post-Kala-Azar Dermal Leishmaniasis: A Literature Review of Current Evidence

open access: yesIndian Journal of Dermatology
Post-kala-azar dermal leishmaniasis (PKDL) is a neglected skin disease that has tremendous epidemiological significance as a reservoir of Leishmania parasites. Relapse, drug resistance, non-compliance to prolonged treatment, poor health-seeking behaviour,
Alka Kumari   +7 more
doaj   +1 more source

Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B

open access: yesThe Turkish Journal of Pediatrics, 2002
Visceral leishmaniasis is a worldwide, disseminated intracellular protozoal infection that usually manifests by fever, hepatosplenomegaly, anemia, thrombocytopenia, leukopenia and hypergammaglobulinemia. Although anemia is a usual finding, Coombs'
Embiya Dilber   +2 more
doaj  

Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children

open access: yesThe Turkish Journal of Pediatrics, 2013
The aim of this study was to investigate the efficacy of a 21-day schedule of liposomal amphotericin B compared to pentavalent antimony salts in the treatment of patients during a first episode of visceral leishmaniasis. In this study, 17 cases of
Hurşit Apa   +5 more
doaj  

Liposomal amphotericin B in critically ill paediatric patients

open access: yes, 2012
What is known and Objective: Literature provides much evidence regarding liposomal amphotericin B treatment for fungal infections in neonates and infants. Relevant data regarding critically ill paediatric patients of older age are scarce.
Falagas, M.E.   +6 more
core  

Liposomal amphotericin B in the treatment of pediatric gastrointestinal basidiobolomycosis. [PDF]

open access: yesJ Med Case Rep
Forooghi M   +5 more
europepmc   +1 more source

Nebulized Liposomal Amphotericin B as an Alternative Therapy for an <i>Aspergillus</i> Tracheal Plaque. [PDF]

open access: yesCase Rep Infect Dis
Valdes-Camacho S   +9 more
europepmc   +1 more source

Can liposomal amphotericin B be used as a preventive measure for cryptococcal meningitis? [PDF]

open access: yesExpert Rev Anti Infect Ther
Schwartz EL, Bahr NC, Rajasingham R.
europepmc   +1 more source

Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis

open access: yes, 2003
Disseminated fungal infection is an important cause of morbidity and mortality, especially in immunocompromised hosts. Amphotericin B is an important part of the therapy and treatment of invasive and life-threatening mycoses.
Dominguez, Delfina C.   +2 more
core  

Home - About - Disclaimer - Privacy